Product
Pregnenolone
Aliases
Neurosteroid
11 clinical trials
13 indications
Indication
Major Depressive DisorderIndication
Chronic Low Back PainIndication
AnxietyIndication
HIVIndication
Post-Traumatic Stress DisorderIndication
MenopauseIndication
PerimenopauseIndication
Alcohol Use DisorderIndication
Bipolar DisorderIndication
Autism Spectrum DisorderIndication
AutismIndication
Social IsolationIndication
Traumatic Brain InjuryClinical trial
NCCIH Development of Pregnenolone as a Treatment for Depression R61 PhaseStatus: Completed, Estimated PCD: 2022-05-31
Clinical trial
Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II TrialStatus: Not yet recruiting, Estimated PCD: 2028-10-01
Clinical trial
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living With HIVStatus: Recruiting, Estimated PCD: 2027-06-30
Clinical trial
Neurosteroid Intervention for PTSD in Iraq/Afghanistan-era VeteransStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A New Intervention to Improve Function in Veterans With Anxiety and DepressionStatus: Not yet recruiting, Estimated PCD: 2028-06-30
Clinical trial
A Neurosteroid Intervention for Menopausal and Perimenopausal DepressionStatus: Recruiting, Estimated PCD: 2025-01-31
Clinical trial
Clinical Medication Development for Bipolar Disorder and Alcohol Use DisordersStatus: Completed, Estimated PCD: 2023-05-01
Clinical trial
Pregnenolone for the Treatment of Alcohol Use DisorderStatus: Recruiting, Estimated PCD: 2028-07-31
Clinical trial
Randomized Controlled Pilot Trial of Pregnenolone in AutismStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Effects of Pregnenolone on Perceived Social Isolation: A Double-blind Randomized Electrical Neuroimaging StudyStatus: Terminated, Estimated PCD: 2021-12-21
Clinical trial
Novel Intervention for Chronic Complex TBI in OEF/OIF/OND VeteransStatus: Not yet recruiting, Estimated PCD: 2026-08-30